EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

IMMUNE SENESCENCE AND EXHAUSTION PHENOTYPE MARKED BY LOSS OF NKG2D AND DNAM-1 NK ACTIVATING SIGNALING AND INCREASED TIM-3 T CD8 CHARACTERIZES ADVANCED MYELOFIBROSIS

M Medeiros, IC Arruda, AG de Carvalho, CAB Garcia, LS Binelli, BL Adjafre, PS Scheucher, JLdS Schiavinato, CL Araujo, AS Lima, RL Pacca, LC Palma und 1 weitere

Hematology, Transfusion and Cell Therapy · 2025-10 · 47 · 104424

DOI: 10.1016/j.htct.2025.104424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematology, Transfusion and Cell Therapy, 2025-10. Verfasst von M Medeiros und 12 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Medeiros, M., Arruda, I., Carvalho, A. D., Garcia, C., Binelli, L., Adjafre, B., Scheucher, P., Schiavinato, J., Araujo, C., Lima, A., Pacca, R., Palma, L., & Pontes, L. D. F. (2025). IMMUNE SENESCENCE AND EXHAUSTION PHENOTYPE MARKED BY LOSS OF NKG2D AND DNAM-1 NK ACTIVATING SIGNALING AND INCREASED TIM-3 T CD8 CHARACTERIZES ADVANCED MYELOFIBROSIS. Hematology, Transfusion and Cell Therapy, 47, 104424. https://doi.org/10.1016/j.htct.2025.104424

Vancouver

Medeiros M, Arruda I, Carvalho AD, Garcia C, Binelli L, Adjafre B, et al. IMMUNE SENESCENCE AND EXHAUSTION PHENOTYPE MARKED BY LOSS OF NKG2D AND DNAM-1 NK ACTIVATING SIGNALING AND INCREASED TIM-3 T CD8 CHARACTERIZES ADVANCED MYELOFIBROSIS. Hematology, Transfusion and Cell Therapy. 2025;47:104424. doi:10.1016/j.htct.2025.104424

BibTeX
@article{Medeiros2025,
  author = {Medeiros, M and Arruda, IC and Carvalho, AG de and Garcia, CAB and Binelli, LS and Adjafre, BL and Scheucher, PS and Schiavinato, JLdS and Araujo, CL and Lima, AS and Pacca, RL and Palma, LC and Pontes, LL de Figueiredo},
  title = {IMMUNE SENESCENCE AND EXHAUSTION PHENOTYPE MARKED BY LOSS OF NKG2D AND DNAM-1 NK ACTIVATING SIGNALING AND INCREASED TIM-3 T CD8 CHARACTERIZES ADVANCED MYELOFIBROSIS},
  journal = {Hematology, Transfusion and Cell Therapy},
  year = {2025},
  volume = {47},
  pages = {104424},
  doi = {10.1016/j.htct.2025.104424}
}
Kostenlos starten →